Sign in

NCT05099679Completed

Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart Study

A Pilot Study for Optimizing Mental Wellbeing and Heart Health for Black Patients With Prostate Cancer

Source: ClinicalTrials.gov · Last updated 29 Jan 2025

Brief summary (registry, in English)

Pilot study to determine the feasibility of providing psychosocial and cardiac rehabilitation services to address socioeconomic health disparities and improve wellbeing for black men with prostate cancer.

Status (registry)
Completed
Study type
Interventional
Enrollment
14 (actual)
First submitted
11 Oct 2021
Start date
18 Nov 2021
Primary completion date
20 Dec 2024
Lead sponsor
Stanford University
NCT number
NCT05099679

What you commit to

  • Study type: Interventional
  • Participants enrolled: 14
  • From 18 Nov 2021 to the primary completion date, 20 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Uncontrolled angina, active acute coronary syndrome (e.g., unstable angina or acute MI) or poorly controlled arrhythmias.
  • In the opinion of the Principal Investigator, have a clinically significant comorbid disease that is likely to affect the ability of the patient to complete the trial, interfere with their ability with measurement of self-reported outcomes.

Who the study is looking for

  • Self-Identify as Black and/or African American.
  • Diagnosed with prostate cancer currently or any time in the past (per medical history; pathology not required, active prostate cancer at time of enrollment is not required).
  • Males \>= age 18.
  • All participants must have a life expectancy of \> 6 months.
  • Participants must have the ability to understand and the willingness to sign a written informed consent document in English, and the willingness/ability to comply with the protocol activities.
  • Ability to wear a face mask during all in-person sessions (when required).
    • Participants must complete the psychosocial intake (Part A, Visit A1) in order to enroll in a cardiac rehabilitation program (Part B).
    • Additional Inclusion Criteria for Part B (Cardiac Services)
  • Have completed the psychosocial intake portion of Visit A1 (as documented by clinical social worker).
  • Meets at least one of the following (\[a\] or \[b\]):
    • planning to receive androgen deprivation on Day 1, or is currently, or was formerly, on androgen deprivation therapy. It is acceptable for participant to switch/transition to another form of androgen deprivation therapy while in the study. Participant may be receiving or planning to receive additional systemic therapy concurrent with androgen deprivation.
    • \^ treatment with single agent testosterone-blocking agents (such as, but not limited to bicalutamide) will also be eligible
    • OR
    • patients with a cardiac risk factor may enroll. Cardiac risk factors include, but are not restricted to: pre-hypertension, hypertension, metabolic syndrome, tobacco history, coronary artery disease, CVA/TIA, peripheral vascular disease, obesity, hypercholesterolemia, hyperglycemia, heart failure, or any other cardiac condition based on the discretion of the investigators.
  • Participants must have an ECOG Performance Status of \<= 2 or at the investigator's discretion, will have the ability to participate in a cardiac rehab program.
  • Participants must be able and willing to follow the cardiac rehabilitation activities.
  • Participant must have a smartphone or tablet to use for the cardiac rehabilitation app.
    • Exclusion Criterion for Part A (Mental Health Services)
    • \* Actively engaging in self harm, or currently on a 5150 or 5250.

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Stanford University
Coordinator of this site? Confirm its status
Palo AltoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.